A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

Clinical trial NCT00813865 · COMPLETED

Trial details

NCT number: NCT00813865
Sponsor: Amicus Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gaucher Disease Type 1 Gaucher Disease Gaucher Disease, Type 1

Start date: 2009-05-11
Primary completion: 2012-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.